| Literature DB >> 27889455 |
Jaya Prabhakaran1, Kiran Kumar Solingapuram Sai2, Francesca Zanderigo1, Harry Rubin-Falcone3, Matthew J Jorgensen4, Jay R Kaplan4, Katharine I Tooke3, Akiva Mintz2, J John Mann1, J S Dileep Kumar5.
Abstract
We recently reported the radiosynthesis and in vitro evaluation of [18F]-2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-(2-fluoroethoxy)benzyl)ethanamine, ([18F]FECIMBI-36) or ([18F]1), an agonist radioligand for 5HT2A/2C receptors in postmortem samples of human brain. Herein we describe the in vivo evaluation of [18F]FECIMBI-36 in vervet/African green monkeys by PET imaging. PET images show that [18F]FECIMBI-36 penetrates the blood-brain barrier and a low retention of radioactivity is observed in monkey brain. Although the time activity curves indicate a somehow heterogeneous distribution of the radioligand in the brain, the low level of [18F]FECIMBI-36 in brain may limit the use of this tracer for quantification of 5-HT2A/2C receptors by PET. Copyright ÂEntities:
Keywords: 5-HT; 5-HT(2A/2C)R; Agonist; PET; Radiotracer
Mesh:
Substances:
Year: 2016 PMID: 27889455 PMCID: PMC5348621 DOI: 10.1016/j.bmcl.2016.11.043
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823